1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPfizer Global Medical Grants for AI in Cancer is sponsored by Pfizer Global Medical Grants. Pfizer Global Medical Grants provide funding for innovative AI frameworks to benefit cancer patients, such as the Prov-GigaPath project which predicts clinically actionable biomarkers based on digital pathology slides from cancer patients.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funding Global Health Through Grants Our grant programs support independent research, quality improvement and education initiatives that find innovative ways to improve patient outcomes in underserved communities around the world.
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s areas of interest. Living Longer with Cancer: Redefining What It Means to Survive The sixth season of Science Will Win, Pfizer's award-winning podcast, focused on cancer.
The six episodes explored the disease from every angle, from its rising incidence in younger populations to the precision medicine tools helping clinicians catch it earlier and treat it more effectively.
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world. Every year, we take stock of the impact our work has on the world, the environment, and people themselves in our Impact Report.
Multiple Myeloma: Shedding Light on a Rare but Complex Blood Cancer Donna is more than a cancer patient: Donna is a wife, mother, grandmother, sister, and friend who has a full life outside of treatment. Her journey with multiple myeloma has revealed depths of resilience and strength that have long served her in all of those roles.
Achieving breakthroughs that change patients’ lives across the globe, especially in underserved communities or disaster-affected communities, is our goal. Which is why we take the health and safety of our colleagues so seriously. We want to share the power of our resources to achieve a healthier world for everyone.
We’re committed to using everything at our disposal—from our medicines and vaccines, to our financial investments and colleagues’ expertise—all in the name of providing quality healthcare services for patients everywhere.
And because our resources allow us to reach so many people, we’re committed to using our global presence and scale to make a difference throughout the world Incredible things can happen when people come together with one shared goal. The future of medicine is happening here, and we’re eager to work alongside inspired and inspirational people who want to improve health around the world. Opportunities for Veterans Leadership.
Honor. A sense of purpose. The qualities you demonstrated as a member of the armed forces are valued at Pfizer.
Explore Veteran Opportunities We’re turning advanced science and technologies into therapies that make a real difference. Join us, and your efforts could impact millions of people. Breakthrough Fellowship Program We want to create a workplace for all.
That’s why we’re committed to increasing diversity and fostering inclusivity with this first-of-its-kind, nine-year fellowship program. Explore Our Fellowship Program Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.
According to the current listing, eligibility includes: Organizations and researchers proposing innovative AI frameworks to improve patient outcomes in cancer. Specific eligibility criteria would be outlined in the individual grant announcements from Pfizer. Confirm the full requirements in the official notice before applying.
The current listing shows $250,000 (example award to Providence). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pfizer Global Medical Grants for AI in Cancer is funded by Pfizer Global Medical Grants. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article